BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29983693)

  • 1. Surgical Strategy for T2 Gallbladder Cancer: Nationwide Multicenter Survey in Korea.
    Lee SE; Kim SW; Han HS; Lee WJ; Yoon DS; Cho BH; Choi IS; Kim HJ; Hong SC; Lee SM; Choi DW; Park SJ; Kim HJ; Jang JY;
    J Korean Med Sci; 2018 Jul; 33(28):e186. PubMed ID: 29983693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea.
    Lee SE; Jang JY; Kim SW; Han HS; Kim HJ; Yun SS; Cho BH; Yu HC; Lee WJ; Yoon DS; Choi DW; Choi SH; Hong SC; Lee SM; Kim HJ; Choi IS; Song IS; Park SJ; Jo S;
    Ann Surg Oncol; 2014 Oct; 21(11):3654-60. PubMed ID: 24743905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
    Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
    Gut Liver; 2016 Jan; 10(1):140-6. PubMed ID: 26347513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and Prognosis.
    Kawahara R; Shirahama T; Arai S; Muroya D; Nomura Y; Fukutomi S; Shirahama N; Takagi K; Goto Y; Akashi M; Maruyama Y; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Horiuchi H; Okuda K; Akagi Y; Tanaka H
    Kurume Med J; 2017 Apr; 63(1.2):15-22. PubMed ID: 28331137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.
    Kim DH; Kim SH; Choi GH; Kang CM; Kim KS; Choi JS; Lee WJ
    World J Surg; 2013 Nov; 37(11):2635-40. PubMed ID: 23959341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.
    Kwon W; Kim H; Han Y; Hwang YJ; Kim SG; Kwon HJ; Vinuela E; Járufe N; Roa JC; Han IW; Heo JS; Choi SH; Choi DW; Ahn KS; Kang KJ; Lee W; Jeong CY; Hong SC; Troncoso AT; Losada HM; Han SS; Park SJ; Kim SW; Yanagimoto H; Endo I; Kubota K; Wakai T; Ajiki T; Adsay NV; Jang JY
    Br J Surg; 2020 Sep; 107(10):1334-1343. PubMed ID: 32452559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
    Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
    J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
    Yun SP; Shin N; Seo HI
    World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.
    Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY
    World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
    Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.
    Jensen EH; Abraham A; Jarosek S; Habermann EB; Al-Refaie WB; Vickers SA; Virnig BA; Tuttle TM
    Surgery; 2009 Oct; 146(4):706-11; discussion 711-3. PubMed ID: 19789030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
    Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
    Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
    He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
    World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical guidelines for the surgical treatment of gallbladder cancer.
    Lee SE; Kim KS; Kim WB; Kim IG; Nah YW; Ryu DH; Park JS; Yoon MH; Cho JY; Hong TH; Hwang DW; Choi DW;
    J Korean Med Sci; 2014 Oct; 29(10):1333-40. PubMed ID: 25368485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical strategies for treatment of T1b gallbladder cancers diagnosed intraoperatively or postoperatively].
    Zhang LF; Hou CS; Guo LM; Tao LY; Ling XF; Wang LX; Xu Z; Xiu DR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):1034-1037. PubMed ID: 29263477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing survival rate and appropriate surgery methods according to tumor location in T2 gallbladder cancer.
    Sung MK; Lee W; Lee JH; Song KB; Kim SC; Kwak BJ; Hwang DW
    Surg Oncol; 2022 Mar; 40():101693. PubMed ID: 34923377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indication of extrahepatic bile duct resection for gallbladder cancer.
    Kurahara H; Maemura K; Mataki Y; Sakoda M; Iino S; Kawasaki Y; Mori S; Arigami T; Kijima Y; Shinchi H; Natsugoe S
    Langenbecks Arch Surg; 2018 Feb; 403(1):45-51. PubMed ID: 28875312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage II gallbladder carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Gastrointest Surg; 2007 May; 11(5):631-7. PubMed ID: 17468922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.